What is a nonspecific sclerotic lesion? | Rounds What is a nonspecific sclerotic lesion? | Rounds
Loading...

What is a nonspecific sclerotic lesion?

Medical Advisory Board
All articles are reviewed for accuracy by our Medical Advisory Board.

Educational purpose only · Not a substitute for professional judgment or the full text of guidelines and labels.

Article Review Status
Submitted
Under Review
Approved

Last updated: July 14, 2026 · View editorial policy

Nonspecific sclerotic lesion

A nonspecific sclerotic lesion is an area in bone that appears more dense (whiter) on imaging, such as X-ray, CT, or MRI, where the exact cause cannot be determined from appearance alone.

Imaging appearance

Sclerosis refers to increased bone density at a focal site. These lesions can be seen on multiple imaging modalities.

Common causes

A nonspecific sclerotic lesion may represent a benign process such as a bone island (enostosis) or healed/latent injury. It may also reflect a degenerative or inflammatory condition.

Potential malignant causes

Some cancers can produce sclerotic (bone-forming) metastases. Multiple myeloma and other marrow disorders can occasionally involve sclerotic components.

Why it is labeled “nonspecific”

Many different conditions can look similar on imaging. Additional clinical context is needed, including symptoms, prior malignancy history, and relevant lab results.

Typical next steps

Further characterization may include comparison with prior imaging to assess stability. More detailed imaging (such as targeted CT) or MRI may be used. Depending on the overall risk assessment, follow-up imaging or biopsy may be considered.

Key risk factors that change management

Prior or current cancer history increases concern for metastatic disease. New or worsening pain increases concern. Progression in size or number over time increases concern. Abnormal blood tests (such as markers of bone or marrow disease) increase concern.

Red flags

Unexplained persistent or progressive bone pain. Known malignancy with new bone lesions. Radiographic progression on serial studies. Systemic symptoms such as unexplained weight loss or night sweats in the appropriate context.

Related Questions